ARCHIVES

Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now

This article is from The Cancer Letter archive.

Vol. 09 No. 46 | December 2, 1983

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

Yarbro Proposal, Clinical Research Should Be “Fun”, Done Without Grants/ Contracts, To Be Heard By ACCC

September 10, 1982

Cancer Control RFA Announcements

March 9, 1979

Afinitor Significantly Reduced Tumor Size In TSC-Related Renal Angiomyolipomas

January 25, 2013

Coordination, Funding Lacking In National Cancer Program: Report

October 7, 1994

In Brief: Pollock Named Director of Surgical Oncology At Ohio State Comprehensive Cancer Center

May 8, 2013